TradingViewTradingView

Axogen Directors Engage in Multiple Stock Transactions

1 minuto di lettura
Reporter NameRelationshipTypeAmountSEC Filing
Tyndall Joseph A.DirectorSell$288,700Form 4
Johnson JohnDirectorSell$43,214Form 4
Neels Guido JDirectorSell$43,214Form 4
Burke William P. Mr.DirectorSell$43,214Form 4
Wendell Amy McbrideDirectorSell$43,214Form 4
Levine Alan MDirectorSell$43,214Form 4
Weiler Kathy JohnsonDirectorSell$43,214Form 4

Joseph A. Tyndall, a Director at Axogen, sold 26,931 shares of Common Stock on June 10, 2025, for a total sale amount of $288,700, at a weighted average price of $10.72 per share. Following this transaction, Tyndall no longer directly owns any Common Stock in Axogen.

John Johnson, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Johnson directly owns 24,943 shares of Axogen.

Guido J Neels, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Neels directly owns 86,743 shares of Axogen.

William P. Burke, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Burke directly owns 24,484 shares of Axogen.

Wendell Amy McBride, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, McBride directly owns 93,826 shares of Axogen.

Alan M Levine, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Levine directly owns 36,743 shares of Axogen.

Kathy Johnson, a Director at Axogen, sold 4,073 shares of Common Stock on June 9, 2025, at a weighted average price of $10.61 per share, totaling $43,214. Following the transaction, Johnson directly owns 6,580 shares of Axogen.